ELGX Endologix Inc

Endologix, Inc. (NASDAQ:ELGX) announces the following Webcast: What: Lippert/Heilshorn Life Sciences Virtual Conference When: March 18, 2008 @ 11:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=127010 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Ben Carmichael, 212-838-3777, bcarmichael@lhai.com If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=127010 or http://www.investorcalendar.com/ Endologix, Inc. develops, manufactures, sells, and markets minimally invasive therapies for the treatment of cardiovascular disease. It offers Powerlink System, a catheter and endoluminal graft (ELG) for the treatment of abdominal aortic aneurysm, a weakening of the wall of the aorta, the artery of the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft. The Powerlink ELG is implanted in the abdominal aorta, which is accessed through the femoral artery. The implantation causes the blood flow to be shunted away from the weakened or aneurysmal section of the aorta resulting in the reduction of pressure and potential for the aorta to rupture. The company provides infrarenal bifurcated systems, suprarenal bifurcated systems, and aortic cuffs and limb extensions. It sells its Powerlink System primarily in the United States, Europe, and Latin America. The company was founded in 1992 as Cardiovascular Dynamics, Inc. and changed its name to Radiance Medical Systems, Inc. in 1999. Further, it changed its name to Endologix, Inc. in 2002. The company is headquartered in Irvine, California. Endologix, Inc. (NASDAQ:ELGX) announces the following Webcast: What: Lippert/Heilshorn Life Sciences Virtual Conference When: March 18, 2008 @ 11:00 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=127010 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Ben Carmichael, 212-838-3777, bcarmichael@lhai.com If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=127010 or http://www.investorcalendar.com/ Endologix, Inc. develops, manufactures, sells, and markets minimally invasive therapies for the treatment of cardiovascular disease. It offers Powerlink System, a catheter and endoluminal graft (ELG) for the treatment of abdominal aortic aneurysm, a weakening of the wall of the aorta, the artery of the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft. The Powerlink ELG is implanted in the abdominal aorta, which is accessed through the femoral artery. The implantation causes the blood flow to be shunted away from the weakened or aneurysmal section of the aorta resulting in the reduction of pressure and potential for the aorta to rupture. The company provides infrarenal bifurcated systems, suprarenal bifurcated systems, and aortic cuffs and limb extensions. It sells its Powerlink System primarily in the United States, Europe, and Latin America. The company was founded in 1992 as Cardiovascular Dynamics, Inc. and changed its name to Radiance Medical Systems, Inc. in 1999. Further, it changed its name to Endologix, Inc. in 2002. The company is headquartered in Irvine, California.